Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults
异源（第三剂）加强免疫接种（使用两种不同新冠疫苗的全剂量或部分剂量）的免疫原性、安全性和反应原性：一项成人4期单盲随机对照试验
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2023.2233400
Costa Clemens, Sue Ann; Marchevsky, Natalie; Kelly, Sarah; Felle, Sally; Eldawi, Ahmed; Rajasingam, Rupetha; Mahmud, Rawan; Lambe, Teresa; Voysey, Merryn; Gonzalez, Isabela; Milan, Eveline Pipolo; Justino, Maria Cleonice; Bibi, Sagida; Aley, Parvinder; Clemens, Ralf; Pollard, Andrew J
